Elios

Elios Launches The Crossover Lock™, A Lock With Real-Time Alerts Worldwide

Retrieved on: 
Wednesday, March 8, 2023
Motorcycle, SALT, Crossover, Mobile phone, Elios

SALT LAKE CITY, March 8, 2023 /PRNewswire-PRWeb/ -- Lock up peace of mind with the strength and security of The Crossover Lock™. The Elios series of The Crossover Locks, launching today, are the world's only locks that send users real-time alerts from anywhere in the world if it's ever cut, bumped, unlocked or moving.

Key Points: 
  • The Elios series of The Crossover Locks™ are the world's only locks that send users real-time alerts worldwide if it's ever cut, bumped, unlocked or moving.
  • SALT LAKE CITY, March 8, 2023 /PRNewswire-PRWeb/ -- Lock up peace of mind with the strength and security of The Crossover Lock™.
  • Rather than using a bulky, heavy lock that can still be cut or broken into, The Crossover Lock™ is a compact solution that alerts users before a break-in or theft happens.
  • "The Crossover Lock™ sends alert notifications in real-time making this the most advanced lock in the world!"

Smart tracker market to grow by 8.22% Y-O-Y from 2022 to 2023: Low prices will drive the adoption of smart trackers- Technavio

Retrieved on: 
Wednesday, December 14, 2022
Innova, XY, OBD, Mars, Incorporated, OBD II, Qorvo, SME, Persistent, BFSI, Geography, Health, Elios, USD, Retail, Mobile phone

Technavio report analyzes the market's competitive landscape and offers information on several market vendors including

Key Points: 
  • Technavio report analyzes the market's competitive landscape and offers information on several market vendors including
    Chipolo doo: The company offers smart trackers such as Chipolo One and Chipolo One Spot.
  • Elios Inc.:The company offers smart trackers such as OBD II and hard-wired.
  • The smart tracker market report provides critical information and factual data, with a qualitative and quantitative study of the market based on market drivers and limitations as well as future prospects.
  • The business process outsourcing market sizeis estimated to grow by USD 75.89 billion with a CAGR of 6.5%during the forecast period 2022 to 2027.

MFE Inspection Solutions Announces New 640 x 512 Handheld OGI Camera with Android-based User Interface

Retrieved on: 
Tuesday, October 11, 2022
Environment, Green Technology, Mining, Minerals, Natural Resources, Public Transport, Other Construction & Property, Rail, Steel, Maritime, Construction & Property, Packaging, Engineering, Transport, Chemicals, Plastics, Building Systems, Automotive Manufacturing, Audio, Video, Aerospace, Manufacturing, Hardware, Other Energy, Utilities, Oil, Gas, Technology, Energy, Quad, UAV, Movement, NDT, OGI, Android, MFE, Solution, LNG, Multimedia, Propane, 640, Safety, Environment, Maintenance, Boston Dynamics, Elios, Methane, RVI, Video game console, Risk management

MFE Inspection Solutions announces the release of the new MFE Handheld Optical Gas Imaging Camera today that will allow operators to visualize harmful gas leaks in real-time and take immediate action.

Key Points: 
  • MFE Inspection Solutions announces the release of the new MFE Handheld Optical Gas Imaging Camera today that will allow operators to visualize harmful gas leaks in real-time and take immediate action.
  • View the full release here: https://www.businesswire.com/news/home/20221011005975/en/
    The MFE OGI Handheld Camera features a 640 x 512 HOT mid-wave infrared camera core and sources its power from its 70wh rechargeable battery handle.
  • (Photo: Business Wire)
    The handheld device features a 640 x 512 HOT mid-wave infrared camera core and sources its power from its 70wh rechargeable battery handle.
  • The MFE Handheld OGI camera is OOOOa (Quad OA) compliant and will ensure air quality and minimize emissions.

MFE Inspection Solutions Brings Autonomous LiDAR Mapping to Customers with New Emesent Partnership

Retrieved on: 
Wednesday, September 7, 2022
Technology, Engineering, Robotics, Aerospace, Manufacturing, Oil, Gas, Energy, Air, Transport, Environment, Sustainability, Software, Hardware, Data Management, Partnership, Mining, Technology, DJI, RVI, Solution, UAV, NDT, Boston, RTK, Boston Dynamics, MFE, Elios, Multimedia, Map, Communication, Lidar, Industry, Aircraft, Online shopping, Surveying, Machine shop, Emese

This partnership will give MFE customers access to the full line of Emesent products including their flagship product Hovermap ST, an autonomy and mapping payload.

Key Points: 
  • This partnership will give MFE customers access to the full line of Emesent products including their flagship product Hovermap ST, an autonomy and mapping payload.
  • View the full release here: https://www.businesswire.com/news/home/20220907006155/en/
    MFE Inspection Solutions brings you the Emesent Hovermap.
  • Dedicated to being a comprehensive inspection solutions provider, MFE is thrilled to bring this new technology to its customers across North America.
  • MFE Inspection Solutions specialists are excited about what the versatility and accuracy of Hovermaps technology can mean for their customers.

Fides Appoints Elios Elsener as New Chairman of the Board

Retrieved on: 
Thursday, June 9, 2022
Acceleration, Credit Suisse, Board of directors, Ecosystem, Solution, Treasury, Growth, Fides, Public sector banks in India, TMS, Technology, Board, ERP, Elios, Management, Bank, Elsener

ZURICH, Switzerland, June 9, 2022 /PRNewswire-PRWeb/ -- Fides Treasury Services Ltd., the global leader in multibank connectivity and communications, today announced that its Board of Directors has appointed Elios Elsener as the company's new chairman, effective immediately.

Key Points: 
  • Under Elsener's leadership, the Board and Fides' executive team will continue to execute on the company's strategy to drive forward its ambitious international growth.
  • "I am excited to become chairman of a talented team that is dedicated to supporting its impressive client community," said Elsener.
  • "We are thrilled to have Elios join us to spearhead a new phase of rapid business acceleration for Fides," said Angehrn.
  • Whether you are using a TMS, ERP, the Fides Multibanking Suite, or any combination, Fides is the only connectivity platform you need.

Elios Therapeutics Announces the Appointment of Mark H.N. Corrigan, M.D. as Chairman of the Board of Directors

Retrieved on: 
Thursday, February 10, 2022
Pharmacia, Sunovion, Industry, Cubist Pharmaceuticals, Growth, American Psychiatric Association, Distinguished Fellow of the British Computer Society, University, Board, Maine Medical Center, Research, Company, Cancer, Therapy, Director, Patient, Psychiatry, Pharmacia & Upjohn, Melanoma, Neoplasm, Nominal interest rate, American, Cornell University, Vaccine, Prunus, Executive, Drug discovery, LLC, Pharmaceutical industry, Elios, Medicine

AUSTIN, Texas, Feb. 10, 2022 /PRNewswire/ --Elios Therapeutics, a biopharmaceutical company developing innovative personalized therapeutic cancer vaccines, today announced the appointment of Mark H.N.

Key Points: 
  • AUSTIN, Texas, Feb. 10, 2022 /PRNewswire/ --Elios Therapeutics, a biopharmaceutical company developing innovative personalized therapeutic cancer vaccines, today announced the appointment of Mark H.N.
  • "It is my pleasure to welcome Dr. Corrigan as our new Chairman of the Board," said Buddy Long, chief executive officer of Elios Therapeutics.
  • Dr. Corrigan has served on the Board of Elios Therapeutics (formerly Perseus Holdings USA) since October 2020.
  • Dr. Corrigan has served on the board of directors of Cubist Pharmaceuticals, Avanir, Colucid Pharmaceuticals, Epirus (Chairman), Novelion (Executive Chairman), Nabriva Therapeutics and BlackThorn (Chairman).

Elios Therapeutics Strengthens Board of Directors with Appointment of Key Financial Executive Michael Caprio

Retrieved on: 
Wednesday, September 29, 2021
Food, Therapy, Safety, Vaccine, Board of directors, Cancer, Audit, RI, Board, Immune system, Compugen (Israeli company), Elios, Immunotherapy, Accounting, Death, Food and Drug Administration, Company, Industry, LLC, Growth, University, Leadership, Commerce, KPMG, Quality control, Organization, Investment, Connecticut, Initial public offering, SEC, Pharmaceutical industry, Risk management

AUSTIN,Texas, Sept. 29, 2021 /PRNewswire/ --Elios Therapeutics, LLC, an immuno-oncology company focused on the development and commercialization of next-generation, immune-mediated technologies for the treatment of cancer, today announced the appointment of Michael Caprio, C.P.A., an accomplished business executive, to the Company's Board of Directors.

Key Points: 
  • AUSTIN,Texas, Sept. 29, 2021 /PRNewswire/ --Elios Therapeutics, LLC, an immuno-oncology company focused on the development and commercialization of next-generation, immune-mediated technologies for the treatment of cancer, today announced the appointment of Michael Caprio, C.P.A., an accomplished business executive, to the Company's Board of Directors.
  • "On behalf of the leadership team, we are pleased to welcome Michael to our Board of Directors during this important period of growth and evolution for Elios."
  • Michael has served on the board of directors of professional, philanthropic, and social organizations, including KATANA Safety and the Greater Providence Chamber of Commerce, RI.
  • "I am delighted to have the opportunity to join the Elios Board at this pivotal time in the Company's life cycle," said Michael Caprio.

Elios Therapeutics Announces Appointment of Phillip Johnson as Chief Financial Officer

Retrieved on: 
Wednesday, June 26, 2019
Elios

AUSTIN, Texas, June 26, 2019 /PRNewswire/ --Elios Therapeutics, a biopharmaceutical company developing innovative autologous, particle-delivered, dendritic cell cancer vaccines, today announced the appointment of Phillip Johnson as chief financial officer, effective immediately.

Key Points: 
  • AUSTIN, Texas, June 26, 2019 /PRNewswire/ --Elios Therapeutics, a biopharmaceutical company developing innovative autologous, particle-delivered, dendritic cell cancer vaccines, today announced the appointment of Phillip Johnson as chief financial officer, effective immediately.
  • "We are delighted to welcome Phil to Elios," said Buddy Long, chief executive officer of Elios Therapeutics.
  • "I am thrilled to join Elios Therapeutics at this exciting time in the Company's growth and development," said Phillip Johnson.
  • Prior to consulting, Mr. Johnson served as chief financial officer forXeris Pharmaceuticals where he raised $65M in equity capital in Series B and C financings.